Ritholtz Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.44M Buy
31,327
+3,020
+11% +$628K 0.11% 115
2026
Q1
$5.98M Buy
28,307
+217
+0.8% +$46.7K 0.1% 129
2025
Q4
$5.77M Buy
28,090
+30
+0.1% +$5.65K 0.11% 124
2025
Q3
$4.4M Buy
28,060
+8
+0% +$1.24K 0.09% 149
2025
Q2
$4.71M Sell
28,052
-325
-1% -$48.2K 0.1% 119
2025
Q1
$3.91M Sell
28,377
-229
-0.8% -$29.2K 0.12% 122
2024
Q4
$3.38M Sell
28,606
-215
-0.7% -$25.1K 0.1% 128
2024
Q3
$3.19M Sell
28,821
-568
-2% -$59.4K 0.1% 146
2024
Q2
$2.89M Sell
29,389
-20,001
-40% -$2.04M 0.1% 147
2024
Q1
$5.53M Sell
49,390
-2,684
-5% -$290K 0.19% 66
2023
Q4
$5.25M Buy
52,074
+1,339
+3% +$133K 0.2% 59
2023
Q3
$4.4M Sell
50,735
-1,372
-3% -$124K 0.2% 66
2023
Q2
$4.93M Buy
52,107
+28,982
+125% +$2.45M 0.22% 59
2023
Q1
$1.75M Buy
23,125
+3,925
+20% +$296K 0.09% 149
2022
Q4
$1.48M Buy
+19,200
New +$1.46M 0.08% 169

Other funds holding CAH

Ritholtz Wealth Management's CAH Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Cardinal Health (CAH) stake by 11% in Q2 2026, buying an estimated $628K and bringing the position to 31,327 shares worth $7.44M. The position accounts for 0.11% of the portfolio, ranked #115.

Ritholtz Wealth Management first reported a position in CAH in Q4 2022 and has held it in 15 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Ritholtz Wealth Management held 31,327 shares of Cardinal Health worth $7.44M as of Q2 2026.
  • Ritholtz Wealth Management bought 3,020 Cardinal Health shares in Q2 2026, an estimated $628K.
  • Cardinal Health made up 0.11% of Ritholtz Wealth Management's portfolio in Q2 2026, its #115 holding.
  • Ritholtz Wealth Management first reported a position in Cardinal Health in Q4 2022 and has held it in 15 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.